Logo image of BIOL

BIOLASE INC (BIOL) Stock Price, Forecast & Analysis

USA - NASDAQ:BIOL - US0909117022 - Common Stock

0.129 USD
-0.02 (-13.19%)
Last: 6/18/2024, 8:15:46 PM
0.109 USD
-0.02 (-15.5%)
After Hours: 6/18/2024, 8:15:46 PM

BIOL Key Statistics, Chart & Performance

Key Statistics
Market Cap4.31M
Revenue(TTM)48.83M
Net Income(TTM)-38258000
Shares33.39M
Float33.29M
52 Week High10.31
52 Week Low0.09
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-14.25
PEN/A
Fwd PEN/A
Earnings (Next)08-08 2024-08-08/amc
IPO1992-11-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


BIOL short term performance overview.The bars show the price performance of BIOL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

BIOL long term performance overview.The bars show the price performance of BIOL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BIOL is 0.129 USD. In the past month the price decreased by -19.73%. In the past year, price decreased by -98.35%.

BIOLASE INC / BIOL Daily stock chart

BIOL Latest News, Press Relases and Analysis

BIOL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.04 217.47B
ISRG INTUITIVE SURGICAL INC 63.62 196.37B
BSX BOSTON SCIENTIFIC CORP 33.58 146.77B
SYK STRYKER CORP 26.86 135.27B
MDT MEDTRONIC PLC 16.29 115.52B
IDXX IDEXX LABORATORIES INC 56.6 57.10B
BDX BECTON DICKINSON AND CO 12.43 50.85B
EW EDWARDS LIFESCIENCES CORP 32.08 48.40B
RMD RESMED INC 25.22 36.43B
GEHC GE HEALTHCARE TECHNOLOGY 16.16 33.86B
PHG KONINKLIJKE PHILIPS NVR- NY 17.01 27.19B
STE STERIS PLC 26.35 25.61B

About BIOL

Company Profile

BIOL logo image BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.

Company Info

BIOLASE INC

27042 Towne Centre Drive, Suite 270

Foothill Ranch CALIFORNIA 92610 US

CEO: John R. Beaver

Employees: 188

BIOL Company Website

Phone: 19493611200

BIOLASE INC / BIOL FAQ

What does BIOL do?

BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.


Can you provide the latest stock price for BIOLASE INC?

The current stock price of BIOL is 0.129 USD. The price decreased by -13.19% in the last trading session.


Does BIOL stock pay dividends?

BIOL does not pay a dividend.


How is the ChartMill rating for BIOLASE INC?

BIOL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is BIOL stock listed?

BIOL stock is listed on the Nasdaq exchange.


Would investing in BIOLASE INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIOL.


BIOL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BIOL Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BIOL. Both the profitability and financial health of BIOL have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIOL Financial Highlights

Over the last trailing twelve months BIOL reported a non-GAAP Earnings per Share(EPS) of -14.25. The EPS increased by 95.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -111.37%
ROE -14222.3%
Debt/Equity 41.66
Chartmill High Growth Momentum
EPS Q2Q%98%
Sales Q2Q%-3.21%
EPS 1Y (TTM)95.89%
Revenue 1Y (TTM)0.13%

BIOL Forecast & Estimates

9 analysts have analysed BIOL and the average price target is 1.99 USD. This implies a price increase of 1441.86% is expected in the next year compared to the current price of 0.129.

For the next year, analysts expect an EPS growth of 98.59% and a revenue growth 2.98% for BIOL


Analysts
Analysts80
Price Target1.99 (1442.64%)
EPS Next Y98.59%
Revenue Next Year2.98%

BIOL Ownership

Ownership
Inst Owners0%
Ins Owners37.15%
Short Float %N/A
Short RatioN/A